Company Imagion Biosystems Limited
Equities
IBX
AU000000IBX6
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 AUD | -2.44% |
|
-10.11% | -77.46% |
29/02 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/01 | Imagion Biosystems CEO Resigns | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research & Development
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +128.74% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +128.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 01/21/01 |
Marie Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 08/17/08 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 28/17/28 |
Director/Board Member | - | 06/16/06 |
Company contact information
![address Imagion Biosystems Limited(IBX)](https://cdn.zonebourse.com/static/address/34912627.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-77.46% | 17.77L | |
-34.15% | 1.47TCr | |
-55.36% | 220.34Cr | |
+17.78% | 183.44Cr | |
-14.62% | 141.92Cr | |
+16.53% | 118.5Cr | |
-24.88% | 86Cr | |
+1.40% | 78Cr | |
-37.13% | 72Cr | |
+19.58% | 57Cr |
- Stock Market
- Equities
- IBX Stock
- Company Imagion Biosystems Limited